Please login to the form below

Not currently logged in
Email:
Password:

AZD9772

This page shows the latest AZD9772 news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca and BGT shelve experimental sepsis drug

CytoFab (AZD9772) did not show any significant improvements versus placebo in respect of the primary endpoint, ventilator-free day, or secondary endpoint including mortality. ... The partnership began in 2009, after AstraZeneca successfully completed a

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics